Carlsbad / HEK / Bradford / PARIS / Logan / Diego / Nahrendorf / San Jose / Santa Cruz / Hiroshima / Nutley / Walkersville / San Diego / Burnaby / /
Company
Tekmira Pharmaceuticals / Toyota / Cambrex / SomaGenics Inc. / Rajeev KG / Barros SA / Ge / Honda / Ipe / USAa / Kazakov SA / /
Country
Japan / Germany / United States / /
Currency
pence / / /
Event
FDA Phase / /
Facility
N terminus / Weir DB / /
IndustryTerm
cancer therapeutics / chemical modification / subgenomic replicon systems / Treatment of HCV / target site / cell-based reporter gene systems / internal ribosome entry site / care for hepatitis C / sshRNA binding site / prior processing / sshRNA target site / hepatitis therapy / internal ribosomal entry site / therapeutic applications / alignment algorithm / /
MedicalCondition
JE / HIV / HCV genotype 1 / typical infection / Male uPA⫹/⫹/SCID / liver cirrhosis / hepatitis / chronic HCV infection / genome-length hepatitis C / HCV genotype / hepatitis C. Hepatology / Cellular cofactors affecting hepatitis C / hepatocellular carcinoma / HCV / HCV infection / virus infection / classical swine fever / robust in vivo HCV infection / infection / HCV RNA / hepatitis A / DF / siRNA-based cancer / intracellular hepatitis C / hepatitis C / inflammatory cytokines / robust HCV infection / shRNAs targeting hepatitis C / chronic liver disease / chimeric mouse HCV infection / chronic hepatitis C / hepatitis C. N. Engl / human disease / /
MedicalTreatment
cancer therapeutics / /
NaturalFeature
McManus MT / /
Organization
American Society for Microbiology / European Union / National Institute of Health / /
Person
Gene Ther / Klaus Klumpp / Yoshio Morikawa / Anne Dallas / J. Virol / Nat / /
Position
Windisch MP / MATERIALS AND METHODS Reporter / General / IRES-linked firefly luciferase reporter / Editor / Manns MP / Foster GR / good model for the human disease / reporter / Judge / /
zjv00914/zjv8861d14z xppws S⫽:09 4/C Fig: 1,2 ArtID: NLM: research-article CE: SSV Editor: Sandri-Goldin Section: Vaccines and Antiviral Agents